2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting
Jørn Herrstedt(Zealand University Hospital), Florian Scotté(Université Paris-Saclay), Raffaele Giusti(CTO Andrea Alesini), Maria-Angeles Garcia-del-Barrio(Clinica Universidad de Navarra), Teresa Smit(The Medical Oncology Centre of Rosebank), Alex Molassiotis(Aston University), Vikas Ostwal(Homi Bhabha National Institute), Matti Aapro(Clinique de Genolier), Christina H. Ruhlmann(University of Southern Denmark), Mitsue Saito(Juntendo University), Paul J. Hesketh(Lahey Hospital and Medical Center), Venkatraman Radhakrishnan(Cancer Institute (WIA)), Mapi Fleury(University of Lausanne), Bernardo L. Rapoport(The Medical Oncology Centre of Rosebank), Hirotoshi Iihara(Gifu University Hospital), Richard J. Gralla(Jacobi Medical Center), Luigi Celio, Ian Olver(The University of Adelaide), Franziska Jahn(University Hospital in Halle), Karin Jordan(Heidelberg University), Alexandre Chan(University of California, Irvine), Kristopher Dennis(University of Ottawa), Rebecca Clark-Snow(American Society of Clinical Oncology), Rudolph M. Navari(World Health Organization - Pakistan), Mary Lou Affronti(Duke University), Paula Sayegh(OU Health Stephenson Cancer Center), Li Zhang(Peking University), L. Schwartzberg(University of Nevada, Reno), Snežana Bošnjak(Oncology Institute of Vojvodina), Ronald Chow(University of Toronto), Ana Zilić(Oncology Institute of Vojvodina), Ernesto Maranzano(University of Perugia)
Cited by 141
Related Papers
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
|Nature|2021|1.4k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
|Annals of Oncology|2018|1.2k